Skip to main content

This job has expired

You will need to login before you can apply for a job.

Associate Director, Precision Medicine, Immuno-Oncology

Employer
Regeneron Pharmaceuticals, Inc.
Location
Tarrytown, NY, United States
Start date
Mar 30, 2021

View more

Job Details

The Associate Director will design and implement biomarker strategies for development programs in the Immuno-Oncology therapeutic area. Development of biomarker strategies include detailed understanding of the proposed mechanism of action of a drug candidate and the clinical study/disease population. The scientist should be able to outline key questions to be addressed in guiding early and late phase clinical trials that utilize appropriate biomarker technologies in biological matrices, including the development of innovative endpoints to impact decision-making. The scientist will be responsible for liasing with research and clinical laboratories to implement testing of clinical samples and subsequent data analysis. Integration into clinical development teams will include clinical study support to outline the biomarker rationale and testing plans in clinical study protocols, informed consent forms and analytical testing plans to support quantitative and statistical analysis.

A day in the life may include the following:
  • Develops Precision Medicine and clinical translational research strategy collaboratively within the Immune-Oncology clinical development program
  • Collaborate with R&D colleagues on immune-oncology translational research (clinical experimental sciences studies)
  • Authors clinical trial protocols and informed consents to outline scientific rationale for biomarker sample collections
  • Manages assay design, validation, implementation to ensure timely data generation during clinical trials with internal and external research laboratories
  • Generates data presentation materials to inform real-time clinical decision making, clinical and biomarker study reports, conference presentations and peer reviewed manuscripts.
  • Responsible for gaining biomarker budget approval for assay development and clinical sample analysis.
This job may be for you if you have:
  • A Ph.D. and/or M.D.
  • 10+ years' experience participating effectively on cross-disciplinary teams in pharmaceutical or biotech industry, including at least 2-5 years in clinical development, with a track record of high impact in drug development.
  • Experience in preclinical, translational and clinical research in oncology, immunology or immune-oncology drug discovery and/or development preferred.
  • Ability to drive, manage, execute and deliver timely results for complex multi-functional projects required
  • Strong communication and presentation skills required
  • High emotional intelligence, organizational skills and collaboration skills required

Does this sound like you? Apply now to take your first steps toward living the Regeneron Way! We have an inclusive and diverse culture that provides amazing benefits including health and wellness programs, fitness centers and stock for employees at all levels!

Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, nationality, national or ethnic origin, civil status, age, citizenship status, membership of the Traveler community, sexual orientation, disability, genetic information, familial status, marital or registered civil partnership status, pregnancy or maternity status, gender identity, gender reassignment, military or veteran status, or any other protected characteristic in accordance with applicable laws and regulations. We will ensure that individuals with disabilities are provided reasonable accommodations to participate in the job application process. Please contact us to discuss any accommodations you think you may need.
#LI-SC1, SKC

Company

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
 
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

Stock Symbol: REGN

Stock Exchange: NASDAQ

FacebookTwitterInstagramYouTube Logo

Company info
Website
Phone
914-847-7000
Location
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert